SJ , sound OK ,, FDA will need then different d
Post# of 148327
FDA will need then different dose safety profile , and information about
Receptor Occupancy Test ( ROT ) .....but why will they delay if this will be it...
To my knowledge , by now they have safety data with 350 , 525 , and 700 mg ..and they have information about ROT....( but who knows , maybe they will need longer time to review this data before accepting ???)
But to me it sounded they want something more , but I really don't know what ....must be not to bad if Q2 of 2020 as earning stay the same ..
And we will see very soon, look like ...